Biopharma Wins $1 In Del. IP Suit Over Ex-CEO's Wrongdoing
A Delaware vice chancellor on Wednesday ruled that, although the former CEO of Macrophage Therapeutics Inc. breached his fiduciary duty to the biopharma company through a "series of conflicted transactions," only...To view the full article, register now.
Already a subscriber? Click here to view full article